Primary Job Title Scientific Advisory Board Primary Organization Loxo Oncology
Gender Male
LinkedIn View on LinkedIn
Dr. Levine is an Associate Attending Physician at Memorial Sloan-Kettering Cancer Center in the Human Oncology and Pathogenesis Program and Leukemia Service and is an Associate Professor of Medicine at Weill Cornell Medical College. He is a physician scientist with expertise in the molecular genetics of myeloid malignancies, including
myeloproliferative neoplasms (MPN) and acute myeloid leukemia (AML).
The focus of the Levine laboratory is to improve the understanding of the genetic basis of myeloid malignancies, with a specific focus on the role of oncogenic disease alleles in the pathogenesis of MPN and AML. He has been involved in the discovery and characterization of disease alleles in MPN and AML patients, including the identification of JAK2 and MPL mutations in MPN patients.
Dr. Levine serves on the editorial board of Blood, Haematologica (Associate Editor) and Clinical Cancer Research and is a member of the International Working Group for Myelofibrosis. He has earned a Young Investigator Award from the American Society of Clinical Oncology, a Fellow Scholar Award from the American Society of Hematology and a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
He is a Scholar of the Leukemia and Lymphoma Society. He serves on the Medical and Scientific Advisory Board of the Leukemia and Lymphoma Society, and is the chair of the Committee on Epigenetics and Genomics of the American Society of Hematology. Dr. Ross L. Levine is an Associate Attending Physician at Memorial-Sloan Kettering Cancer Center, an Associate Professor of Medicine at Weill Cornell Medical College, and is the Laurence Joseph Dineen Chair in Leukemia Research at MSKCC.
Dr. Levine manages a research lab that is focused on targeted therapies in myeloid malignancies, and is interested in the application of next generation sequencing technology to the practice of medicine in hematologic cancers.Dr. Levine trained in internal medicine at Massachusetts General Hospital, and in hematology-oncology at the Dana Farber Cancer Institute, earning board certification in these specialties. He received his M.D. from The Johns Hopkins University School of Medicine and his A.B. degree from Harvard College.
